Use of an intravenous sclerosing foam (3% sodium tetradecyl sulfate) for treatment of orbital varix in a dog

Rebecca S. Saunders; Brian A. Scansen; Stephen S. Jung; Hooman Khabiri; David A. Wilkie

doi:10.1111/vop.12456

Use of an intravenous sclerosing foam (3% sodium tetradecyl sulfate) for treatment of orbital varix in a dog

Veterinary Ophthalmology ◽

10.1111/vop.12456 ◽

2017 ◽

Vol 21 (2) ◽

pp. 194-198 ◽

Cited By ~ 1

Author(s):

Rebecca S. Saunders ◽

Brian A. Scansen ◽

Stephen S. Jung ◽

Hooman Khabiri ◽

David A. Wilkie

Keyword(s):

Sodium Tetradecyl Sulfate ◽

Orbital Varix

Download Full-text

BRTO vs PARTO for gastric variceal bleeding using sodium tetradecyl sulfate (STS) in a single U.S. medical center

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2016.12.1005 ◽

2017 ◽

Vol 28 (2) ◽

pp. S165-S166

Author(s):

R Charalel ◽

N Saad ◽

S Kim

Keyword(s):

Variceal Bleeding ◽

Medical Center ◽

Sodium Tetradecyl Sulfate

Download Full-text

Sclerotherapy of telangiectasias: A prospective, randomized, comparative clinical trial of hypertonic glucose versus sodium tetradecyl sulfate

Vascular Medicine ◽

10.1177/1358863x21992853 ◽

2021 ◽

pp. 1358863X2199285

Author(s):

Oksana Vasilyevna Bukina ◽

Aleksander Aleksandrovich Sinitsyn ◽

Andrey Viktorovich Pelevin

Keyword(s):

Clinical Trial ◽

Sodium Tetradecyl Sulfate ◽

Median Score ◽

Primary Efficacy ◽

Point Scale ◽

Prospective Randomized Clinical Trial ◽

Hypertonic Glucose ◽

Venous Diseases ◽

Group 3

To compare the disappearance of the telangiectasias after sclerotherapy with 75% glucose (HG) versus 0.2% sodium tetradecyl sulfate (STS). This prospective, randomized clinical trial compared the results of sclerotherapy of the telangiectasias with HG and STS. The primary efficacy end point was telangiectasia disappearance within 14, 28, 42, and 56 days following treatment. The clearing of the vessels was assessed using a six-point scale (from 0 to 5). A total of 159 women were treated (81 in the STS group; 78 in the HG group). The median score of the vessels clearing (IQR) was significantly lower in the STS group than in the HG group: 3 (2–4) versus 4 (3–5) after 56 days, p < 0.001. Pigmentation was frequently observed in the STS group (38.3% vs 2.6%; p < 0.001). In conclusion, throughout the entire follow-up period, sclerotherapy of telangiectasias with glucose was significantly superior to that with STS. Moreover, pigmentation and intravascular clots frequently occurred with STS treatment. Registered at the Russian Registry of Treatment of Chronic Venous Diseases (RRT CVD); ID: VRCVD 1.005.

Download Full-text